ATE158719T1 - Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung - Google Patents
Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendungInfo
- Publication number
- ATE158719T1 ATE158719T1 AT91400743T AT91400743T ATE158719T1 AT E158719 T1 ATE158719 T1 AT E158719T1 AT 91400743 T AT91400743 T AT 91400743T AT 91400743 T AT91400743 T AT 91400743T AT E158719 T1 ATE158719 T1 AT E158719T1
- Authority
- AT
- Austria
- Prior art keywords
- hexetidine
- salts
- pharmaceutical composition
- ophthalmic
- derivatives
- Prior art date
Links
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004867 hexetidine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR909004945A FR2661091B1 (fr) | 1990-04-18 | 1990-04-18 | Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE158719T1 true ATE158719T1 (de) | 1997-10-15 |
Family
ID=9395848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91400743T ATE158719T1 (de) | 1990-04-18 | 1991-03-20 | Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0453337B1 (de) |
| JP (1) | JPH04234818A (de) |
| AT (1) | ATE158719T1 (de) |
| AU (1) | AU643772B2 (de) |
| BR (1) | BR9101544A (de) |
| CA (1) | CA2039566A1 (de) |
| DE (1) | DE69127767T2 (de) |
| DK (1) | DK0453337T3 (de) |
| ES (1) | ES2109937T3 (de) |
| FR (1) | FR2661091B1 (de) |
| HU (1) | HUT57985A (de) |
| MC (1) | MC2217A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0512104A1 (de) * | 1990-11-26 | 1992-11-11 | Warner-Lambert Company | Stabilisierte hexahydro-pyrimidinamine verbindungen in wässriger lösung und verfahren zum herstellen derselben |
| DE10147186A1 (de) * | 2001-09-25 | 2003-04-24 | Beiersdorf Ag | Wirkstoffkombinationen aus Polyhexamethylenbiguanid-Hydrochlorid und Distearyldimethylammoniumchlorid und Zubereitungen, solche Wirkstoffkombinationen enthaltend |
| US9737609B2 (en) * | 2014-08-20 | 2017-08-22 | Professional Compounding Centers Of America (Pcca) | Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE540230A (de) * | 1954-08-02 | |||
| FR2552305B1 (fr) * | 1983-09-22 | 1985-12-20 | Salkin Andre | Composition a pouvoir bactericide eleve contenant un biguanide et une pyrimidine |
| EP0215136B1 (de) * | 1985-09-02 | 1988-06-22 | Artesan Pharma Gesellschaft mit beschränkter Haftung | Hexetidin 1,3-Bis-(2-ethylhexyl)-hexahydro-5-methyl-5-pyrimidinamin enthaltendes therapeutisch wirkendes Mittel, sowie Verfahren zum Herstellen desselben und Verwendung als vaginales Desinfektionsmittel |
| US4666517A (en) * | 1986-06-04 | 1987-05-19 | Colgate-Palmolive Co. | Antiplaque oral composition |
-
1990
- 1990-04-18 FR FR909004945A patent/FR2661091B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-20 EP EP91400743A patent/EP0453337B1/de not_active Expired - Lifetime
- 1991-03-20 DE DE69127767T patent/DE69127767T2/de not_active Expired - Fee Related
- 1991-03-20 DK DK91400743.0T patent/DK0453337T3/da active
- 1991-03-20 ES ES91400743T patent/ES2109937T3/es not_active Expired - Lifetime
- 1991-03-20 AT AT91400743T patent/ATE158719T1/de not_active IP Right Cessation
- 1991-03-22 MC MC912178A patent/MC2217A1/fr unknown
- 1991-04-02 CA CA002039566A patent/CA2039566A1/en not_active Abandoned
- 1991-04-17 JP JP3112393A patent/JPH04234818A/ja active Pending
- 1991-04-17 AU AU75132/91A patent/AU643772B2/en not_active Ceased
- 1991-04-17 BR BR919101544A patent/BR9101544A/pt not_active Application Discontinuation
- 1991-04-18 HU HU911272A patent/HUT57985A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69127767D1 (de) | 1997-11-06 |
| FR2661091A1 (fr) | 1991-10-25 |
| CA2039566A1 (en) | 1991-10-19 |
| HUT57985A (en) | 1992-01-28 |
| EP0453337B1 (de) | 1997-10-01 |
| EP0453337A3 (en) | 1992-11-25 |
| AU643772B2 (en) | 1993-11-25 |
| JPH04234818A (ja) | 1992-08-24 |
| DE69127767T2 (de) | 1998-04-30 |
| BR9101544A (pt) | 1991-12-10 |
| ES2109937T3 (es) | 1998-02-01 |
| DK0453337T3 (da) | 1998-05-18 |
| HU911272D0 (en) | 1991-10-28 |
| MC2217A1 (fr) | 1993-02-02 |
| FR2661091B1 (fr) | 1994-10-21 |
| AU7513291A (en) | 1991-10-24 |
| EP0453337A2 (de) | 1991-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
| DK0418339T3 (da) | Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv | |
| DE3851203D1 (de) | Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums. | |
| HUP9800794A2 (hu) | (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása | |
| DE3855113D1 (de) | Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht | |
| DE69719931D1 (de) | Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren | |
| DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| ATE109350T1 (de) | Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie. | |
| DE68924006D1 (de) | Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung. | |
| ATE84716T1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten. | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| ATE108658T1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
| ATE126061T1 (de) | Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum. | |
| BR9708388A (pt) | Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação. | |
| ATE158719T1 (de) | Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung | |
| ATE112960T1 (de) | Anthocyanidine zur behandlung von augenkrankheiten. | |
| ATE23112T1 (de) | Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks. | |
| NO890801D0 (no) | Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer. | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| DE3584426D1 (de) | Verwendung von spergualin oder eines seiner pharmazeutisch akzeptablen salze zur herstellung eines transplantation-immunitaet unterdrueckenden und anti-allergischen mittels. | |
| ATE78160T1 (de) | Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien. | |
| DE69431320D1 (de) | Verwendung von menschlichem Interferon-d zur Herstellung eines Arzneimittels zur Behandlung von Atemwegserkrankungen in Katzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |